BPTRX
Price
$196.02
Change
-$5.96 (-2.95%)
Updated
Feb 21 closing price
Net Assets
8.21B
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

BPTRX vs GFACX

Header iconBPTRX vs GFACX Comparison
Open Charts BPTRX vs GFACXBanner chart's image
Baron Partners Retail
Price$196.02
Change-$5.96 (-2.95%)
VolumeN/A
Net Assets8.21B
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
BPTRX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BPTRX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPTRX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. BPTRX (8.21B). BPTRX (0.00) and GFACX (0.00) have matching dividends . BPTRX was incepted earlier than GFACX: BPTRX (22 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. BPTRX (5.19). GFACX has a lower initial minimum investment than BPTRX: GFACX (250) vs BPTRX (2000). BPTRX annual gain was more profitable for investors over the last year : 34.02 vs. GFACX (10.15). BPTRX return over 5 years is better than : 119.09 vs. GFACX (32.83).
BPTRXGFACXBPTRX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years24 years-
Gain YTD-6.8432.980-230%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets8.21B304B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year34.0210.15335%
Returns for 3 years23.1517.69131%
Returns for 5 years119.0932.83363%
Returns for 10 years423.2955.63761%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding